Palliative radiotherapy for gastric cancer-related bleeding: a systematic review and meta-analysis of bleeding response and dose-response relationships.

Authors

Ruka Iguchi, Nobuki Imano, Tetsuo Saito, Shota Miyoshi, Takaaki Matsuura, Daisuke Kawahara, Ikuno Nishibuchi, May Abdel-Wahab, Yuji Murakami

Published in

Japanese journal of radiology. Oct 17, 2026. Epub Oct 17, 2026.

Abstract

Palliative radiotherapy is commonly used to control bleeding in advanced gastric cancer; however, the optimal dose-fractionation regimen as well as the dose-response relationship remain unclear. We aimed to evaluate the effectiveness of radiotherapy for gastric cancer-related bleeding and its association with dose fractionation.
We systematically searched PubMed, Scopus, Web of Science, Cochrane Library, and Ichushi-Web for studies published between January 2000 and August 2026 on palliative radiotherapy for gastric cancer-related bleeding. The primary endpoint was bleeding response rate. A random-effects meta-analysis was performed to estimate the pooled response rates. Meta-regression and subgroup analyses were conducted to explore dose-response relationships. Meta-regression was performed using study-level median biologically effective dose (BED) values.
A total of 31 studies were included. The pooled bleeding response rate was 75.9% (95% confidence interval, 69.7-81.2), with significant heterogeneity (I²= 67.5%). Egger's test suggested small study effects (P = 0.012). Meta-regression analysis demonstrated an association between a higher BED and an increased likelihood of response (P = 0.010). Subgroup analyses showed that higher BED categories were associated with higher response rates (P = 0.005). The pooled rebleeding rate was 32.4%. The median overall survival and rebleeding-free survival were 3.8 and 3.4 months, respectively. Radiotherapy was generally well tolerated, with a low incidence of grade ≥ 3 toxicities.
Palliative radiotherapy is an effective and well-tolerated treatment for gastric cancer-related bleeding. Although study-level meta-regression identified a statistical association between higher BED and hemostatic response, this may largely reflect selection bias and methodological limitations rather than a true dose-response relationship. Given the poor prognosis of this population, shorter dose-fractionation regimens are appropriate for many patients, whereas higher-BED regimens remain reasonable for selected patients.

PMID:
42888364
Bibliographic data and abstract were imported from PubMed on 17 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.